Abstract
Bisphenol A (BPA), the highest volume chemical produced in the whole world is widely used in the production of polycarbonate plastics and epoxy resins. Polycarbonate plastics are used especially in the manufacture of consumer products. The exposure of BPA to humans occurs through food contamination from polycarbonate bottles and food and beverage cans. Dust is also a contributor to the total daily exposure of BPA. Thus, BPA has a high potential for human consumption. The U.S. Food and Drug Administration (FDA) recently announced concern about the safety of BPA and the need for more research data. This article reviews toxicity of BPA in general and kidney in particular using clinical and experimental literature. BPA is toxic to aquatic organisms, animals and humans. BPA is cytotoxic and mutagenic and exerts various adverse effects on immune, endocrine, reproductive, developmental and nervous systems in animals and human and exhibits toxicity by all routes of exposure. Metabolism of BPA is much more rapid in humans than in rodents. BPA increases estrogen metabolism in the kidney and upregulates cytochrome p-450 aromatase activity by means of steroidogenesis. BPA acts as biomarker for renal disease and exhibits nephrotoxicity. BPA toxicity with reference to human exposure level and also carcinogenicity are lacking. While focusing on kidney, this review suggests that further research is required to evaluate the molecular mechanism of BPA induced nephrotoxicity. Protective role of antioxidants against BPA induced toxicity / nephrotoxicity is discussed in this literature.
Keywords: Antioxidants, bisphenol A (BPA), environmental estrogen, kidney, oxidative stress, toxicity.
Current Molecular Pharmacology
Title:Nephrotoxicity of Bisphenol A (BPA) -An Updated Review
Volume: 6
Author(s): Sivakumar J. T. Gowder
Affiliation:
Keywords: Antioxidants, bisphenol A (BPA), environmental estrogen, kidney, oxidative stress, toxicity.
Abstract: Bisphenol A (BPA), the highest volume chemical produced in the whole world is widely used in the production of polycarbonate plastics and epoxy resins. Polycarbonate plastics are used especially in the manufacture of consumer products. The exposure of BPA to humans occurs through food contamination from polycarbonate bottles and food and beverage cans. Dust is also a contributor to the total daily exposure of BPA. Thus, BPA has a high potential for human consumption. The U.S. Food and Drug Administration (FDA) recently announced concern about the safety of BPA and the need for more research data. This article reviews toxicity of BPA in general and kidney in particular using clinical and experimental literature. BPA is toxic to aquatic organisms, animals and humans. BPA is cytotoxic and mutagenic and exerts various adverse effects on immune, endocrine, reproductive, developmental and nervous systems in animals and human and exhibits toxicity by all routes of exposure. Metabolism of BPA is much more rapid in humans than in rodents. BPA increases estrogen metabolism in the kidney and upregulates cytochrome p-450 aromatase activity by means of steroidogenesis. BPA acts as biomarker for renal disease and exhibits nephrotoxicity. BPA toxicity with reference to human exposure level and also carcinogenicity are lacking. While focusing on kidney, this review suggests that further research is required to evaluate the molecular mechanism of BPA induced nephrotoxicity. Protective role of antioxidants against BPA induced toxicity / nephrotoxicity is discussed in this literature.
Export Options
About this article
Cite this article as:
Gowder J. T. Sivakumar, Nephrotoxicity of Bisphenol A (BPA) -An Updated Review, Current Molecular Pharmacology 2013; 6 (3) . https://dx.doi.org/10.2174/1874467207666140410115823
DOI https://dx.doi.org/10.2174/1874467207666140410115823 |
Print ISSN 1874-4672 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4702 |
Call for Papers in Thematic Issues
Advances in the Diagnosis and Treatment of Head and Neck Disease
Head and neck diseases encompass a wide range of conditions affecting the oral cavity, pharynx, larynx, nasal passages, sinuses, salivary glands, and other structures of the head and neck region. These diseases can have significantly on essential function, such as breathing, swallowing, speaking, as well as the quality of life. ...read more
Common Mechanisms Underpinning Neurodevelopmental Disorders and Psychiatric Diseases
A growing number of large-scale epidemiologic studies have strongly suggested that common mechanisms may be shared by aberrant brain development and psychiatric disorders. There is now an appreciation of the synergic roles of genetic variants and environmental stress, which profoundly affect genome integrity and reshape brain development. This can lead ...read more
New Cell Death Regulation Drugs for Cardiovascular Diseases
Cardiovascular diseases are the leading cause of mortality worldwide, with aberrant cell death processes playing a crucial role in their pathogenesis. Cell death in these diseases encompasses not only well-studied forms of apoptosis but also includes a variety of complex modes such as mitochondrial permeability transition (MPT)-driven necrosis, entotic cell ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer’s disease
Central Nervous System Agents in Medicinal Chemistry Targeting Transcription Factors for Cancer Therapy
Current Pharmaceutical Design Role of Sirtuins and Calorie Restriction in Neuroprotection: Implications in Alzheimers and Parkinsons Diseases
Current Pharmaceutical Design The Regulatory Mechanisms and Clinical Significance of Lnc SNHG4 in Cancer
Current Pharmaceutical Design Anticancer Potential of Aguerin B, a Sesquiterpene Lactone Isolated from <i>Centaurea behen</i> in Metastatic Breast Cancer Cells
Recent Patents on Anti-Cancer Drug Discovery Gene Expression Analysis Approach to Establish Possible Links Between Parkinson's Disease, Cancer and Cardiovascular Diseases
CNS & Neurological Disorders - Drug Targets Tumor Control by Manipulation of the Human Anti-Apoptotic Survivin Gene
Current Cancer Therapy Reviews Clinical Pharmacokinetic and Metabolism of PET Radiotracers for Imaging P-glycoprotein in Chemoresistant Tumor of Colorectal Cancer
Current Drug Metabolism B7-H3-targeted Radioimmunotherapy of Human Cancer
Current Medicinal Chemistry Critical Enzymes Involved in Endocannabinoid Metabolism
Protein & Peptide Letters Nicotinic Acetylcholine Receptor Interaction with β -Amyloid: Molecular, Cellular, and Physiological Consequences
Current Alzheimer Research Microsatellite Instability as a Predictor of Outcomes in Colorectal Cancer in the Era of Immune-Checkpoint Inhibitors
Current Drug Targets A Systematic Review of Selected Musculoskeletal Late Effects in Survivors of Childhood Cancer
Current Pediatric Reviews Hypoxic Tumor Microenvironment and Cancer Cell Differentiation
Current Molecular Medicine Medullary Thyroid Cancer: A Promising Model for Targeted Therapy
Current Molecular Medicine Sweet and Sour - Oxidative and Carbonyl Stress in Neurological Disorders
CNS & Neurological Disorders - Drug Targets RGD-based Therapy: Principles of Selectivity
Current Pharmaceutical Design Metal Ions and Metal Complexes in Alzheimer’s Disease
Current Pharmaceutical Design Safety of Nanoparticles in Medicine
Current Drug Targets QSAR Studies to Predict Activity of HSP90 Inhibitors
Current Topics in Medicinal Chemistry